Comparison between Chavda Infra IPO and Saroja Pharma IPO.
IPO Details
Chavda Infra IPO is a SME Fixed Price IPO proposed to list at NSE SME while Saroja Pharma IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of Chavda Infra IPO is up to ₹41.08 Cr whereas the issue size of the Saroja Pharma IPO is up to ₹8.66 Cr. The final issue price of Chavda Infra IPO is ₹65.00 per share and of Saroja Pharma IPO is ₹84.00 per share.
IPO Timetable
Chavda Infra IPO opens on Sep 12, 2023, while Saroja Pharma IPO opens on Aug 31, 2023. The closing date of Chavda Infra IPO and Saroja Pharma IPO is Sep 14, 2023, and Sep 05, 2023, respectively.
| | Chavda Infra IPO | Saroja Pharma IPO |
|---|
| Anchor Bid Date | Sep 11, 2023 | |
| Issue Open | Sep 12, 2023 | Aug 31, 2023 |
| Issue Close | Sep 14, 2023 | Sep 05, 2023 |
| Basis Of Allotment (Tentative) | Sep 20, 2023 | Sep 08, 2023 |
| Initiation of Refunds (Tentative) | Sep 21, 2023 | Sep 11, 2023 |
| Credit of Share (Tentative) | Sep 22, 2023 | Sep 12, 2023 |
| Listing date (Tentative) | Sep 25, 2023 | Sep 13, 2023 |
| Anchor Lockin End date 1 | Oct 20, 2023 | |
| Anchor Lockin End date 2 | Dec 19, 2023 | |
Financials & KPIs
Chavda Infra IPO P/E ratio is 9.72, as compared to Saroja Pharma IPO P/E ratio of 23.25.
Shares Offered
In the Chavda Infra IPO Retail Individual Investors (RII) are offered 22,12,000 shares while in Saroja Pharma IPO retail investors are offered 22,12,000 shares. Qualified Institutional Buyers (QIB) are offered 12,64,000 shares in Chavda Infra IPO and in Saroja Pharma IPO.
| | Chavda Infra IPO | Saroja Pharma IPO |
|---|
| Anchor Investor Reservation | 18,96,000 shares | |
| Market Maker Reservation | 3,36,000 shares | 54,400 shares |
| QIB | 12,64,000 shares | |
| NII | 9,48,000 shares | 5,15,200 shares |
| RII | 22,12,000 shares | 5,15,200 shares |
| Total | 63,20,000 shares | 10,30,400 shares |
Bids Received (Subscription)
Chavda Infra IPO subscribed 126.04x in total, whereas Saroja Pharma IPO subscribed 8.86x.
